CIK 0001124105 · Accelerated filer<br>Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562020050
- Phone
- (858) 284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-09 | Ye Weiguo Chief Operating Officer | Option exercise | +3,000 | $0.75 | $2K | 703,000 |
| 2026-06-09 | Ye Weiguo Chief Operating Officer | Sale | −3,000 | $6.15 | $18K | 700,000 |
| 2026-06-09 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −3,000 | 835,701 | ||
| 2026-06-09 | Ye Weiguo Chief Operating Officer | Option exercise | +14,500 | $0.75 | $11K | 714,500 |
| 2026-06-09 | Ye Weiguo Chief Operating Officer | Sale | −14,500 | $6.14 | $89K | 700,000 |
| 2026-06-09 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −14,500 | 847,919 | ||
| 2026-06-08 | Bergmann Joshua Benjamin GC and Corporate Secretary | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2026-06-08 | Luo Ying Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2026-06-05 | Ye Weiguo Chief Operating Officer | Option exercise | +15,401 | $0.75 | $12K | 715,401 |
| 2026-06-05 | Ye Weiguo Chief Operating Officer | Sale | −15,401 | $6.40 | $99K | 700,000 |
| 2026-06-05 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −15,401 | 862,419 | ||
| 2026-06-04 | Ye Weiguo Chief Operating Officer | Option exercise | +19,575 | $0.75 | $15K | 719,575 |
| 2026-06-04 | Ye Weiguo Chief Operating Officer | Sale | −19,575 | $6.13 | $120K | 700,000 |
| 2026-06-04 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −19,575 | 877,820 | ||
| 2026-05-26 | Ye Weiguo Chief Operating Officer | Option exercise | +4,000 | $0.75 | $3K | 704,000 |
| 2026-05-26 | Ye Weiguo Chief Operating Officer | Sale | −4,000 | $6.10 | $24K | 700,000 |
| 2026-05-26 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −4,000 | 897,395 | ||
| 2026-05-22 | Ye Weiguo Chief Operating Officer | Option exercise | +3,500 | $0.75 | $3K | 703,500 |
| 2026-05-22 | Ye Weiguo Chief Operating Officer | Sale | −3,500 | $6.08 | $21K | 700,000 |
| 2026-05-22 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −3,500 | 901,395 |
Page 2 of 11 · 215 trades